Summit Therapeutics (SMMT) Receivables Refunds (2018 - 2024)
Summit Therapeutics' Receivables Refunds history spans 7 years, with the latest figure at $557000.0 for Q4 2024.
- For Q4 2024, Receivables Refunds fell 34.32% year-over-year to $557000.0; the TTM value through Dec 2024 reached $557000.0, down 34.32%, while the annual FY2024 figure was $557000.0, 34.32% down from the prior year.
- Receivables Refunds reached $557000.0 in Q4 2024 per SMMT's latest filing, down from $660000.0 in the prior quarter.
- In the past five years, Receivables Refunds ranged from a high of $15.7 million in Q4 2021 to a low of $557000.0 in Q4 2024.
- Average Receivables Refunds over 5 years is $7.2 million, with a median of $6.8 million recorded in 2020.
- Peak YoY movement for Receivables Refunds: soared 109.5% in 2020, then plummeted 93.73% in 2023.
- A 5-year view of Receivables Refunds shows it stood at $9.9 million in 2020, then skyrocketed by 59.24% to $15.7 million in 2021, then plummeted by 63.26% to $5.8 million in 2022, then plummeted by 85.29% to $848000.0 in 2023, then plummeted by 34.32% to $557000.0 in 2024.
- Per Business Quant, the three most recent readings for SMMT's Receivables Refunds are $557000.0 (Q4 2024), $660000.0 (Q3 2024), and $953000.0 (Q2 2024).